Advertisement

Topics

CRISPR Therapeutics Raises $56M In IPO, Half Its Rivals’ Haul

22:48 EDT 18 Oct 2016 | Xconomy

CRISPR Therapeutics has raised $56 million in an initial public offering, making it the third company developing human medicines with the gene editing system CRISPR-Cas9 to make the IPO leap in 2016. Split between Switzerland and Cambridge, MA, CRISPR Therapeutics sold 4 million shares at $14 apiece, raising about 25 percent less than the target […]

Original Article: CRISPR Therapeutics Raises $56M In IPO, Half Its Rivals’ Haul

NEXT ARTICLE

More From BioPortfolio on "CRISPR Therapeutics Raises $56M In IPO, Half Its Rivals’ Haul"

Quick Search
Advertisement
 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...